1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cardiometabolic Drug News NOVEMBER 2014

Cardiometabolic Drug News NOVEMBER 2014

  • November 2014
  • -
  • Espicom Business Intelligence
  • -
  • 8 pages

Industry Brief - FDA Advisory Committee Recommends Edoxaban Approval In NVAF
Industry Brief - Bayer Completes Acquisition Of Merck's Consumer Care Business; Collaboration Comes Into Effect
Industry Brief - BHV/Libbs Enter Licensing Deal For Remogliflozin
Industry Brief - Cardiorentis/Roche Enter Collaboration For Ularitide
Industry Brief - BI/Lilly Revise Operational Structure Of Diabetes Alliance
Industry Brief - FDA Approves Once-Daily Xigduo XR For Adults With Type II Diabetes
Industry Brief - FDA Accepts NDA Filing For Empagliflozin/Metformin FDC
Industry Brief - Contrave Available In US Pharmacies
Industry Brief - FDA Approves Arbor's Sotylize
Industry Brief - The Medicines Company Sees US Angiomax Patent Victory
Industry Brief - Takeda Responds To Judgement In Actos Case
Industry Brief - Ranbaxy Gains US Fenofibrate Approval
Industry Brief - Cardio3 Receives Approval To Begin C-Cure Phase III HF Trial In Switzerland
Industry Brief - Amgen Files Alirocumab Lawsuit Against Sanofi/Regeneron
Industry Brief - Capricor To Acquire Natriuretic Peptide Patent Rights
Industry Brief - NeuroSearch Signs Agreement To Transfer Phase I-II Projects
Industry Brief - Novo Nordisk Invests In New Danish Laboratory Facility
Industry Brief - FDA Medicare Study Results For Pradaxa Revealed

Table Of Contents

Cardiometabolic Drug News NOVEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.